reading between the lines using PMJH's forensic research mind20 Jan 2021 09:21
RM's statement:
"The trial is both a test of the drug, and a test of how technology can be utilised to deliver and manage the administration of an inhaled broad-spectrum antiviral to vulnerable patients in the context of a pandemic"
Hasn't SNG positioned itself as bio company with a drug/protein that is safe and works but also as a tech company that will disrupt traditional ways of providing care and treatment? Surely this new treatment model helps gov protect their citizens but also their medical assets.
Also, it is safe to assume that SNG is confident on the safety and efficacy of SNG001. Could one (using pmjh's forensic insight) be led to believe that the home trials will be used to help draft the new rule book on distance care giving, as well as fine tuning the nebuliser before manufacturers start increasing production. Am I wrong to believe that they are a couple of patents in the pipelines?
Finally, in terms of logistics and couriers, would it be far fetched to imagine SNG already talking to Amazon (or vice versa) as a possible partner to deliver the product (nebuliser & drug) to patients? I believe a similar deal was reached between the UK Gov and Amazon when it wanted to ramp up testing kits delivery.
It seems to me that everything has been designed to line up and be perfectly synced, ahead of the final announcement which will deliver a new drug, a new product, and a new methodology. I think the USA market will be the spark that ignites the SNG fireworks. not long to go.
Thanks yet again to pmjh's research and calm outlook. Dafad is up there too, with that amazing Kensas University youtube interview.
Sign In
Follow the stocks
